Inactive Instrument
InMed Pharmaceuticals Inc Stock Canadian Securities Exchange
Stocks
IN
CA4576371062
Biotechnology & Medical Research
| Market Cap | 6.92M 4.87M 4.27M 3.94M 3.67M 461M 7.04M 47.23M 18.33M 227M 18.31M 17.9M 792M | P/E 2024 |
-0.26x | P/E 2025 | -0.39x |
|---|---|---|---|---|---|
| Enterprise Value | -3.46M -2.44M -2.13M -1.97M -1.84M -230M -3.52M -23.6M -9.16M -114M -9.15M -8.94M -396M | EV / Sales 2024 |
-714,273x | EV / Sales 2025 | -1,305,911x |
| Free-Float |
99.88% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: InMed Pharmaceuticals Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 63 | 2016-06-15 |
Netta Jagpal
DFI | Director of Finance/CFO | 53 | 2024-02-19 |
| Chief Operating Officer | 57 | 2022-07-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Adams
BRD | Director/Board Member | 63 | 2016-06-15 |
Andrew Hull
CHM | Chairman | 63 | - |
Nicole Lemerond
BRD | Director/Board Member | 51 | 2022-08-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 6.92M | |
| +0.44% | +8.87% | +71.40% | +133.26% | 57.65B | |
| -1.32% | +17.12% | +79.02% | +99.82% | 55.14B | |
| -1.28% | +2.68% | -12.60% | -13.79% | 23.53B | |
| +1.79% | +4.38% | +5.94% | +405.31% | 23.11B | |
| -1.93% | +11.11% | +34.89% | -7.86% | 18.14B | |
| +1.28% | +6.92% | +38.76% | -29.66% | 16.84B | |
| +0.24% | +5.98% | +23.45% | +184.72% | 13.68B | |
| +0.14% | +9.60% | +33.31% | - | 12.97B | |
| +1.83% | +4.58% | +77.42% | +132.45% | 12.38B | |
| Average | +0.11% | +5.68% | +39.07% | +113.03% | 25.94B | |
| Weighted average by Cap. | -0.10% | +4.87% | +48.45% | +116.81% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.6 3.24 2.83 2.62 2.44 306.12 4.68 31.38 12.18 151.06 12.16 11.89 526.26 | 4.94 3.48 3.05 2.81 2.62 329.09 5.03 33.73 13.1 162.39 13.08 12.78 565.74 |
| Net income | -7.68M -5.4M -4.73M -4.37M -4.07M -511M -7.81M -52.38M -20.34M -252M -20.31M -19.85M -879M | -8.16M -5.75M -5.03M -4.64M -4.33M -543M -8.31M -55.71M -21.63M -268M -21.59M -21.11M -934M |
| Net Debt | -5.65M -3.98M -3.48M -3.22M -3M -376M -5.75M -38.57M -14.98M -186M -14.95M -14.62M -647M | -10.38M -7.31M -6.4M -5.9M -5.51M -691M -10.56M -70.83M -27.5M -341M -27.46M -26.84M -1.19B |
Employees
-
